Form 8 (DD) - Biocompatibles International plc

Form 8 (DD) - Biocompatibles International plc

Form 8 (DD) - Biocompatibles International plc

Form 8 (DD) - Biocompatibles International plc


Released: 17/01/2011

FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT

(INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code") 1. KEY INFORMATION

(a) Identity of the party to the offer or person acting in Peter Geigle concert making the disclosure:

(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant Biocompatibles securities this form relates:

International plc Use a separate form for each offeror/offeree (d) Status of person making the disclosure: Person acting in concert with the e.g. offeror, offeree, person acting in concert with offeree the offeror/offeree (specify name of offeror/offeree) (e) Date dealing undertaken: 11 January 2011 to 14 January 2011 (f) Has the party previously disclosed, or is it today No disclosing, under the Code in respect of any other party to this offer? 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

Class of relevant security: Ordinary 21 53/94p Interests Short positions Number % Number %

(1) Relevant securities owned and/or controlled: 780,929 1.98 0 0

(2) Derivatives (other than options): 0 0 (3) Options and agreements to purchase/sell: 0 0 780,929 1.98 0 0 TOTAL:

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists: Ordinary

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/ Date Number of Price per unit security sale securities volume weighted average prices 386.5p Ordinary Sale 11.01.2011 - 150,000 14.01.2011 (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price relevant description reference per security e.g. opening/closing a long/short securities unit e.g. CFD position, increasing/reducing a long/short position (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Option relevant description purchasing, securities price date money security e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. Ord Free Share - 1,800 0 - 01/10/ nil awards under 2011 Biocompatibles 1,550 0 Share Incentive 11/09/ Plan 827 0 2012 27/09/ 2103 (vesting dates) (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit (if security applicable) e.g. subscription, conversion

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or

understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None (c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions) NO Supplemental Form 8 (SBL) NO Date of disclosure: 17 January 2011 Contact name: Peter Geigle Telephone number: +44 (0) 1252 732645

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

vendor

Back to press releases